Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
UBE3D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SLC39A8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRKRA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AGTPBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NSUN7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LRRC37A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PTPN4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MSI2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUDT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIGK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCMF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEP78 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB3IP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928195 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAR1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GALNT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on